期刊文献+

miR-195表达在乳腺癌细胞对阿霉素药物敏感性中的意义 被引量:4

Significance of microRNA-195 expression in breast cancer cells to adriamycin drug sensitivity
下载PDF
导出
摘要 目的调控miR-195在乳腺癌细胞中的表达对阿霉素药物(ADR)敏感性的影响及其作用机制进行研究。方法利用脂质体将成熟miR-195模拟物(miR-195mimic)及阴性对照转染至乳腺癌细胞MCF-7,采用实时定量聚合酶链式反应(RT-PCR)检测细胞中miR-195的表达变化;采用MTT比色法及流式细胞术(FCM)检测转染miR-195模拟物及其对照经ADR作用后细胞的增殖及凋亡;Western-blot检测细胞中Raf-1、P-gp、Bcl-2蛋白的表达。结果转染miR-195mimic后,明显上调了细胞中miR-195的表达水平(P<0.01);在miR-195mimic与ADR联合作用后,明显抑制了细胞的增殖,其敏感性与对照组相比,提高近2.5倍(P<0.05),同时促进了细胞的凋亡(P<0.05);Western-blot检测发现在转染miR-195mimic后,细胞中Raf-1蛋白及BCL-2、P-gp蛋白的表达显著降低(P<0.01)。结论在乳腺癌细胞中,miR-195作为抑癌基因,能够有效促进乳腺癌细胞对ADR所介导的化疗敏感性,其作用机制至少部分是通过miR-195负性调控Raf-1蛋白的表达来实现。 Objective Study on the possibility of regulating Micro RNA (miRNA)195 expression to increase the sensitivity of the breast cancer cell (MCF-7) to adriamycin (ADR) and its mechanism .Methods Transfect through liposome the mature Micro RNA(miRNA)195 mimic and its negative contrast into MCF-7 and detect chan-ges of Micro RNA(miRNA)195 in the cells by Real-time PCR ;detect Micro RNA(miRNA)195 mimic and its contrast by MTT colorimetric method and FCM ,and detect cells′reproduction and apoptosis after the effect of ADR ;detect by Western-blot the protein expression of Raf-1 ,P-gp and Bcl-2 in the cells .Results The Micro RNA(miRNA) 195 expression in the cells increases significantly (P〈0 .01) after the transfection of Micro RNA (miRNA)195 mimic;the combined effect of Micro RNA (miRNA)195 mimic and ADR significantly suppresses the cell reproduction ,its sensitivity increases almost 2 .5 times(P〈0 .05) in comparison with the control group ,and the apoptosis rate of the cells increases ;it is observed that ,by Western-blot detection ,the protein expressions of Raf-1 ,Bcl-2 and P-gp in the cells decrease significantly(P〈0 .01) after the transfection of Micro RNA (miRNA)195 mimic .Conclusion Micro RNA(miRNA)195 ,as the tumor suppressor gene in breast cancer cells ,can effectively increase the chemotherapy sensitivity of breast cancer cells to ADR mediation .Its mechanism is realized at least partly by Micro RNA (miRNA) 195′s negative regulation on Raf-1 protein .
出处 《检验医学与临床》 CAS 2014年第15期2043-2046,共4页 Laboratory Medicine and Clinic
基金 四川省卫生厅科研课题(2012120293) 重庆市科委基金基础项目(2011jjA10060)
关键词 乳腺癌细胞 阿霉素 药物敏感性 微小RNA breast cancer cell adriamycin drug sensitivity microRNA
  • 相关文献

参考文献16

  • 1Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast Cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 2Kastl L,Brown I,schofield AC.miRNA-34a is associated with docetaxel resistance in human breast Cancer cells[J],Breast Cancer Res Treat,2012,131(2):445-454.
  • 3Zhang QQ,Xu H,Huang MB,et al.MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion[J].Neuro Oncol,2012,14(3):278-287.
  • 4Fei X,Qi M,Wu B,et al.MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder Cancer T24 cells by regulating GLUT3 expression[J].FEBS Lett,2012,586(4):392-397.
  • 5Ellis LM,Hicklin DJ.Resistance to targeted therapies: re-fining anticancer therapy in the era of molecular oncology[J].Clin Cancer Res,2009,15(24):7471-7478.
  • 6Foekens JA,Sieuwerts AM,Smid M,et al.Four miRNAs associated with aggressiveness of lymph node-negative,estrogen receptor-positive human breast Cancer[J].Proc Natl Acad Sci U S A,2008,105(35):13021-13026.
  • 7Kastl L,Brown I,Schofield AC.miRNA-34a is associated with docetaxel resistance in human breast Cancer cells[J].Breast Cancer Res Treat,2012,131(2):445-454.
  • 8Kovalchuk O,Filkowski J,Meservy J,et al.Involvement of microRNA-451 in resistance of the MCF-7 breast Cancer cells to chemotherapeutic drug doxorubicin[J].Mol Cancer Ther,2008,7(7):2152-2159.
  • 9Xia L,Zhang D,Du R,et al.miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric Cancer cells[J].Int J Cancer,2008,123(2):372-379.
  • 10Liu L,Chen L,Xu Y,et al.microRNA-195 promotes ap-optosis and suppresses tumorigenicity of human colorectal Cancer cells[J].Biochem Biophys Res Commun,2010,400(2):236-240.

二级参考文献13

  • 1Bartel DP. MicroRNAs:genomics,biogenesis,mechanism and function[J].Cell,2004.281-297.doi:10.1016/S0092-8674(04)00045-5.
  • 2Lim LP,Lau NC,Weinstein EG. The microRNAs of Caenorhabditis elegans[J].Genes and Development,2003.991-1008.
  • 3Esquela-Kerscher A,Slack FJ. Oncomirs-microRNAs with a role in cancer[J].Nature and Resources,2006.259-269.doi:10.1038/nrc1840.
  • 4Chen YQ,Wang XX,Yao XM. MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency[J].American Journal of Nephrology,2011.549-559.
  • 5Sekiya Y,Ogawa T,Iizuka M. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation[J].Journal of Cellular Physiology,2011.2535-2542.
  • 6Zhu H,Yang Y,Wang Y. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirtl[J].Cardiovascular Research,2011.75-84.
  • 7Soon PS,Tacon LJ,Gill AJ. miR-195 and miR-4835p identified as predictors of poor prognosis in adrenocortical cancer[J].Clinical Cancer Research,2009.7684-7692.doi:10.1158/1078-0432.CCR-09-1587.
  • 8Wang X,Wang J,Ma H. Downregulation of miR195 correlates with lymph node metastasis and poor prognosis in colorectal cancer[J].Medical Oncology,2011.
  • 9Finnerty JR,Wang WX,Hebert SS. The miR-15/107 group of microRNA genes:evolutionary biology,cellular functions,and roles in human diseases[J].Journal of Molecular Biology,2010.491-509.doi:10.1016/j.jmb.2010.07.051.
  • 10He JF,Luo YM,Wan XH. Biogenesis of MiRNA195 and its role in biogenesis,the cell cycle,and apoptosis[J].Journal of Biochemical and Molecular Toxicology,2011.404-408.

共引文献2

同被引文献32

  • 1隋华,周利红,刘宣,殷佩浩,周宁,王炎,孙珏,范忠泽,李琦.COX-2介导MDR1/P-gp调控人结肠癌细胞多药耐药的研究[J].中国癌症杂志,2011,21(4):241-246. 被引量:11
  • 2Earl HM,Vallier AL,Hiller L,et al. Effects of the addition of gem- citabine, and paetitaxel-first sequencing,in neoadjuvant sequential epimbicin, eyclophosphamide, and paelitaxel for women with high- risk early breast eaneer(Neo-tAnGo) :an open-label,2x2 faetorial randomised phase 3 trial [ J ]. Lancet Oncol, 2014, 15 ( 2 ) : 201-212.
  • 3Chan S,Campone M,Santoro A,et al. A phase I clinical and phar- maeokinetic study evaluating vinflunine in combination with epiru- biein as first-line treatment in metastatic breast cancer[ J]. Cancer Chemother Pharmacol,2014,73 (5) :903-910.
  • 4Chang WT, Hsieh BS, Cheng HL, et al. Progesterone augments epi- rubicin-induced apoptosis in HA22T/VGH cells by increasing oxi- dative stress and upregulating Fas/FasL[ J]. J Surg Res ,2014,188 (2) :432-441.
  • 5Yamamoto Y, Hyodo I, Takigahira M, et al. Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum( II )-incorporating miceUes (NC-4016) on a human gastric cancer model[J]. Int J Cancer, 2014,135 ( 1 ) :214-223.
  • 6Karamitsos A, Kokkas V, Goulas A, et al. Ocular surface and tear film abnormalities in women under adjuvant chemotherapy for breast cancer with the 5-Fluorouracil, Epiruhicin and Cyclophos- phamide(FEC) regimen[J]. Hippokratia,2013,17(2) :120-125.
  • 7Steger GG, Greil R,Lang A, et al. Epirubicin and docetaxel with i or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase HI study(ABCSG-24) [ J] Ann 0ncol,2014,25 (2) :366-371.
  • 8Shaft T,Zager PG,Sozio SM,et al. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients:the Choices for Healthy Outcomes in Caring for ESRD(CHOICE) Study[J]. Am J Kidney Dis, 2014,64(3 ) : 443-451.
  • 9张慧,符立梧.多药耐药相关蛋白及其在肿瘤耐药中的作用[J].药学学报,2011,46(5):479-486. 被引量:31
  • 10颜昕,阮文雯,王效民,丁鑫,郝兰香,廖洪锋,潘超.多药耐药对肝癌细胞增殖、凋亡、侵袭活性、耐药机制及丝裂原活化蛋白激酶表达的影响[J].肿瘤,2012,32(7):507-515. 被引量:8

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部